- Home
- SCPH vs LXEO Comparison
SCPH vs LXEO Comparison
Compare SCPH & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- LXEO
- Stock Information
- Founded
- SCPH 2013
- LXEO 2017
- Country
- SCPH United States
- LXEO United States
- Employees
- SCPH N/A
- LXEO N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- LXEO
- Sector
- SCPH Health Care
- LXEO
- Exchange
- SCPH Nasdaq
- LXEO Nasdaq
- Market Cap
- SCPH 299.0M
- LXEO 279.7M
- IPO Year
- SCPH 2017
- LXEO 2023
- Fundamental
- Price
- SCPH $5.62
- LXEO $5.21
- Analyst Decision
- SCPH Buy
- LXEO Strong Buy
- Analyst Count
- SCPH 3
- LXEO 7
- Target Price
- SCPH $12.00
- LXEO $15.29
- AVG Volume (30 Days)
- SCPH 2.4M
- LXEO 426.8K
- Earning Date
- SCPH 11-12-2025
- LXEO 11-12-2025
- Dividend Yield
- SCPH N/A
- LXEO N/A
- EPS Growth
- SCPH N/A
- LXEO N/A
- EPS
- SCPH N/A
- LXEO N/A
- Revenue
- SCPH $49,969,000.00
- LXEO N/A
- Revenue This Year
- SCPH $108.95
- LXEO N/A
- Revenue Next Year
- SCPH $78.30
- LXEO N/A
- P/E Ratio
- SCPH N/A
- LXEO N/A
- Revenue Growth
- SCPH 107.79
- LXEO N/A
- 52 Week Low
- SCPH $1.94
- LXEO $1.45
- 52 Week High
- SCPH $6.28
- LXEO $11.72
- Technical
- Relative Strength Index (RSI)
- SCPH 52.96
- LXEO 60.70
- Support Level
- SCPH N/A
- LXEO $4.90
- Resistance Level
- SCPH $5.62
- LXEO $5.56
- Average True Range (ATR)
- SCPH 0.04
- LXEO 0.29
- MACD
- SCPH -0.21
- LXEO 0.02
- Stochastic Oscillator
- SCPH 99.56
- LXEO 61.96
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.